Mushrooms Meet Metabolism: Wedding Startups Race to Bottle New Enzyme as Döner Shops Wonder If They'll Need a Rebrand

Science, but make it merch

Researchers announced an enzyme that seems to steer fat production and cholesterol. In the lab that's a sentence with footnotes; in Wedding it's a brand strategy, a podcast, and a waiting list. The discovery was framed in cautious, elegant prose—Foucault would have called it biopower with a PayPal link—and the local market translated it into something easier to drink: hope in a glass syringe.

How it unfolds on the street

• A two‑person startup in a former print shop near Seestraße repositions itself as a "metabolic concierge," offering 12‑week enzyme coaching, artisanal enzyme shots (vegan ceramic cups only), and a Discord for troubleshooting cravings. Their pitch deck includes a chart that flirts suggestively with causation.
• An afternoon clinic run by a former fitness influencer advertises a "cholesterol reset" special—complimentary kombucha and a mandatory 15‑minute guided breathwork session. The clinic's receptionist asks whether you'd like the enzyme in a shot or a suppository; the answer is your problem.
• Mustafa, who has run his döner place on a corner of Wedding for 22 years, was handed a flyer by a startup rep offering to make his menu "leaner and more Instagrammable." Mustafa folded the flyer into his apron and asked whether "cholesterol‑friendly döner" would still attract customers or just confuse them. His answer was a look that could curdle yogurt.

Cultural collateral damage

What the press release called "translational potential" arrives as small print on house rules. Longtime residents see another layer of cultural erasure: Turkish bakeries replaced by labs that sell enzyme‑infused pastries at three times the price of a real croissant. The same street that used to host late‑night cheap eats now hosts evening tastings where you can pair microdoses of mushrooms with a talk on lipidomics by a man in a cardigan.

This is gentrification's classic move: take a public good—food, music, endurance—and repackage it as a boutique problem you alone can solve for a fee. Debord would have loved the spectacle: a molecular discovery projected as a lifestyle choice.

The startup script (orthogonal, profitable, inevitable)

1. Acquire science. Rename it. Trademark the verb form.
2. Hire an aesthetic director to make lab coats look aspirational.
3. Offer an early access tier with branded glass vials and a monthly community call where the CEO talks about "holistic lipid alignment."

Investors call it "biohacking with defensibility." Workers call it "a great excuse to sell subscriptions to people who already pay rent to feel moral." The product is sold as a modest, penetrating intervention into the body—language that sounds clinical but reads like a pickup line at a wellness mixer.

Club culture, daytime edition

No one on our street is promising eternal disco stamina, but the logic is similar: optimize what you consume so you can keep consuming. The enzyme becomes a brag—stickers on water bottles, referral codes at brunch—an odd status symbol for people whose main performance metric is looking both exhausted and curated. It's less about health than credibility: the hard to swallow truth is that novelty trumps evidence when it comes with good lighting.

What gets lost

The conversation rarely includes systemic stuff—food deserts, rent pressure, the fact that fatty food is often cheap and dense with cultural meaning. Instead we get individual remedies. Proust wrote about memory being summoned by a madeleine; here memory is summoned by a menu item and then politely edited away.

A note from Mustafa (translated)

"If people want less fat, I will sell less fat. But if I sell less fat and the price goes up, then what? Who gets to eat everything and who gets the diet?" He paused, towel over his shoulder, and asked whether "cholesterol‑friendly" meant anything if you can't afford it.

Verdict

The enzyme discovery is real and interesting. The commercialization in Wedding is predictable and performative. Science has always been useful; what's new is our ability to monetize even the correction of our appetites. We are learning to treat metabolism like a membership: private seminars, monthly fees, and carefully curated disclaimers.

Foucault, Debord, and Mustafa would all have a different recommended response: a theory, a pamphlet, and a well‑made döner. All three might agree on one thing—selling solutions without changing the system is a lot like rearranging furniture on a sinking ship, but nicer to look at.

Disclaimer: Yes, some people will get real benefit from future therapies. No, that doesn't mean we should clap politely while the rest of the city gets priced out of its own dinner.